Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Grieve

Showing results (91-100 of 128) with videos related to

Pageof 13
Sort By:
Plos One|August 17, 2022
Cost-effectiveness of alternative minimum recall intervals between whole blood donationsZia Sadique, Sarah Willis, Kaat De Corte, et al.
Journal of Cancer Policy|November 10, 2025
Inequalities in the utilisation of curative-intent treatments for early-stage non-small cell lung cancer across urban and rural areas: A population-based study in EnglandEva Kagenaar, David G Lugo-Palacios, Ajay Aggarwal, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 24, 2022
Local Instrumental Variable Methods to Address Confounding and Heterogeneity when Using Electronic Health Records: An Application to Emergency SurgerySilvia Moler-Zapata, Richard Grieve, David Lugo-Palacios, et al.
Diabetologia|May 31, 2025
Comparative effectiveness of alternative second-line oral glucose-lowering therapies for type 2 diabetes: a precision medicine approach applied to routine dataStephen O'Neill, Patrick Bidulka, David G Lugo-Palacios, et al.
BMJ (Clinical Research Ed.)|September 29, 2016
Cancer Drugs Fund requires further reformRichard Grieve, Keith Abrams, Karl Claxton, et al.
Ophthalmology|December 2, 2009
Verteporfin photodynamic therapy cohort study: report 1: effectiveness and factors influencing outcomesSimon P Harding, Keith Tomlin, Barnaby C Reeves, et al.
Trials|May 27, 2017
Initiating change locally in bullying and aggression through the school environment (INCLUSIVE) trial: update to cluster randomised controlled trial protocolChris Bonell, Anne Mathiot, Elizabeth Allen, et al.
PLOS Global Public Health|November 30, 2023
The importance of investing in data, models, experiments, team science, and public trust to help policymakers prepare for the next pandemicRichard Grieve, Youqi Yang, Sam Abbott, et al.
BMJ Open|September 28, 2021
Protocol for an observational cohort study investigating personalised medicine for intensification of treatment in people with type 2 diabetes mellitus: the PERMIT studyPatrick Bidulka, Stephen O'Neill, Anirban Basu, et al.
PLOS Global Public Health|June 14, 2024
Correction: The importance of investing in data, models, experiments, team science, and public trust to help policymakers prepare for the next pandemicRichard Grieve, Youqi Yang, Sam Abbott, et al.
Pageof 13

Showing results (91-100 of 128) with videos related to

Sort By:
Pageof 13
Plos One|August 17, 2022
Cost-effectiveness of alternative minimum recall intervals between whole blood donationsZia Sadique, Sarah Willis, Kaat De Corte, et al.
Journal of Cancer Policy|November 10, 2025
Inequalities in the utilisation of curative-intent treatments for early-stage non-small cell lung cancer across urban and rural areas: A population-based study in EnglandEva Kagenaar, David G Lugo-Palacios, Ajay Aggarwal, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 24, 2022
Local Instrumental Variable Methods to Address Confounding and Heterogeneity when Using Electronic Health Records: An Application to Emergency SurgerySilvia Moler-Zapata, Richard Grieve, David Lugo-Palacios, et al.
Diabetologia|May 31, 2025
Comparative effectiveness of alternative second-line oral glucose-lowering therapies for type 2 diabetes: a precision medicine approach applied to routine dataStephen O'Neill, Patrick Bidulka, David G Lugo-Palacios, et al.
BMJ (Clinical Research Ed.)|September 29, 2016
Cancer Drugs Fund requires further reformRichard Grieve, Keith Abrams, Karl Claxton, et al.
Ophthalmology|December 2, 2009
Verteporfin photodynamic therapy cohort study: report 1: effectiveness and factors influencing outcomesSimon P Harding, Keith Tomlin, Barnaby C Reeves, et al.
Trials|May 27, 2017
Initiating change locally in bullying and aggression through the school environment (INCLUSIVE) trial: update to cluster randomised controlled trial protocolChris Bonell, Anne Mathiot, Elizabeth Allen, et al.
PLOS Global Public Health|November 30, 2023
The importance of investing in data, models, experiments, team science, and public trust to help policymakers prepare for the next pandemicRichard Grieve, Youqi Yang, Sam Abbott, et al.
BMJ Open|September 28, 2021
Protocol for an observational cohort study investigating personalised medicine for intensification of treatment in people with type 2 diabetes mellitus: the PERMIT studyPatrick Bidulka, Stephen O'Neill, Anirban Basu, et al.
PLOS Global Public Health|June 14, 2024
Correction: The importance of investing in data, models, experiments, team science, and public trust to help policymakers prepare for the next pandemicRichard Grieve, Youqi Yang, Sam Abbott, et al.
Pageof 13